.

Kristen L. Worley

Co-Chair, Catastrophic Claims Litigation

Co-Chair, Cannabis Law Practice

Portrait of Kristen L. Worley

Kristen Worley brings more than 22 years of litigation and trial experience to Marshall Dennehey’s Casualty Department. Throughout her career, she has represented a variety of clients in New Jersey and Pennsylvania in the areas of product liability, premises liability, commercial motor vehicle and, specifically, companies specializing in paratransit and non-emergency medical transport lines of business. Additionally, she has handled product defect cases and negligent maintenance cases for elevators and escalators throughout PA and NJ.  Kristen routinely defends elevator mechanics in their depositions to defend modernization cases, door strikes, mislevelings, improper passenger extractions by third parties, etc. Kristen has also been admitted on a pro hac basis at the request of her clients to litigate matters with significant exposure in Delaware and New York.  

Kristen is driven by results; whether that be identifying those matters that are ripe for early resolution or engaging in targeted discovery for those cases that must be tried. Litigation with a purpose is the key to her success both behind the scenes and in the courtroom. This case management methodology and approach to litigation has proven successful over the years, assisting Kristen in securing the 3rd largest negligent entrustment verdict in New Jersey in 2017.   

Kristen is an honors graduate of Trenton State College and earned her law degree at Rutgers School of Law in Camden, New Jersey. In addition to the state courts of Pennsylvania and New Jersey, Kristen is admitted in the District Court of New Jersey, the Eastern District of Pennsylvania and the United States Third Circuit Court of Appeals.  Active in the legal community, she is a member of the International Association of Defense Counsel and the prestigious Federation of Defense and Corporate Counsel. 

Kristen resides in Southern New Jersey with her family where she enjoys spending her time involved in the local youth soccer community.

    • Rutgers Law School (J.D., 1999)
    • The College of New Jersey (B.S., magna cum laude, 1996)
    • New Jersey, 1999
    • Pennsylvania, 1999
    • U.S. District Court District of New Jersey
    • U.S. District Court Eastern District of Pennsylvania
    • U.S. Court of Appeals 3rd Circuit
    • Pennsylvania Bar Association
    • Strategically defended and obtained the dismissal of a Laidlow claim asserted by the plaintiff who was acting within the course and scope of his employment with the defendant when he sustained a significant workplace injury. In a 37-page written opinion granting the defendant’s motion for summary judgment and addressing several other applications, the court ruled the plaintiff failed to establish that his employer committed an intentional and malicious act sufficient to circumvent the workers’ compensation exclusivity provision. In reaching this conclusion, the court applied the Millison “conduct” and “context” prongs, reasoning that the absence of prior accidents or evidence suggesting the plaintiff’s employer intentionally disabled a safety device, the lack of pre-incident OSHA violations or post-accident efforts by the employer to deceive OSHA, and the undeniable determination that the plaintiff’s incident was “part and parcel” of industrial life, all warranted the entry of summary judgment in favor of the defendant employer and the dismissal of the plaintiff’s claim. You can read the opinion here.  

Results

Summary Judgment Obtained in Significant Workplace Injury Case

We secured a motion for summary judgment in a significant workplace injury case involving a Laidlow claim. The court ruled that the plaintiff had failed to establish that his employer had committed an intentional and malicious act sufficient to circumvent the workers’ compensation exclusivity provision.

Jury Defense in High-Stakes Catastrophic Litigation Case

We obtained a defense verdict in the U.S. District Court for the Eastern District of Pennsylvania in a case where the plaintiff sought $24.1M for alleged property damages and lost revenue.     In 2014, our client defendant, a marine construction company, was retained by the U.S. Navy to conduct pile driving activities at the Philadelphia Navy Yard. The plaintiff, a neighboring commercial property owner, alleged that our client's pile driving and related activities damaged its property and caused it to lose revenue. All other defendants settled before trial. The plaintiff claimed $20 million in damages against our client. A bifurcated trial began on January 17, 2023. The plaintiff’s demand dropped throughout the nine-day liability phase, which involved numerous scientific and engineering experts and other witnesses. On January 27, 2023, the jury returned its unanimous verdict, attributing 60% of the fault to plaintiff itself and 25% to the Navy, which resulted in a defense verdict for our client. As a result of the defense verdict on liability, there will be no damages phase.  

Thought Leadership

Defense Digest

On the Pulse…Navigating the Complexities of Cannabis Litigation: Marshall Dennehey’s Multidisciplinary Approach to a Rapidly Evolving Industry

December 1, 2025

Cannabis litigation is on the rise and impacts multiple facets of law. Marshall Dennehey’s Cannabis Law Practice Group is adept at helping clients navigate this evolving legal landscape, offering a full suite of legal services, no matter what type of claim a cannabis business or its insurers may be facing. Our services include analysis of insurance coverage and the defense of commercial general liability (CGL), professional liability, cybersecurity, employment, workers’ compensation, and health care claims. Coverage Our team defends insurers and managing general agents (MGAs) against cannabis-related coverage and bad faith claims, including those related to equipment breakdown, application of protective safeguard endorsements, business interruption, and crop losses. We are familiar with the industry’s underwriting goals and policies that reflect the unique risks of this segment.  CGL Claims  Commercial general liability claims encompass a wide range of casualty matters relevant to cannabis operations and recreational product usage. These claims may include auto liability matters, product liability claims, “Gram-Shop,” and other retail accessory risks, such as landlord liability and delivery service claims. We defend typical retail claims at cannabis dispensaries, such as falls and even assault claims involving altercations between patrons and, occasionally, employees. In doing so, we utilize varied technology assets of clients, such as surveillance and body cam footage and, where appropriate, pursue loss-transfer claims against third parties. Additionally, we defend clients in cannabis product liability matters, including claims of tainted product, and have identified a team of experts in the various fields of toxicology, analytical chemistry, food safety, and forensic science to assist in defending these claims.  Professional Liability Claims Our vast history and focus on defending professional liability claims across a broad range of industries affords our attorneys a unique advantage in defending claims brought against cannabis professionals, such as growers, cultivators, consultants, accountants, lawyers, MGAs, adjusters, and others who work within this space.  Cybersecurity Claims  Ransomware attacks and data breaches threaten cannabis operators and their obligation to safeguard their customers’ sensitive medical and personal data. Likewise, security breaches with track-and-trace software designed to track cannabis from “seed-to-sale” can interrupt an operator’s regulatory compliance. In the event of a data compromise, our cyber team is available to quickly mobilize and mitigate the damage caused by a ransomware attack. Employment and Workers’ Compensation Claims With the growing approval of recreational cannabis usage and the increasing number of cultivators and dispensaries popping up to meet consumer demand, it is not surprising that employment and workers’ compensation lawsuits in these fields are trending upwards. Our attorneys defend facility owners and operators when wage-and-hour disputes, discrimination and harassment, and retaliation claims arise. We also represent insurers and employers in workplace injury and occupational hazard claims. Our approach extends to cannabis industry-specific risks that include cultivation and manufacturing operations, as well as retail sales and distribution environments. Health Care Claims While many states have legalized the medical use of cannabis, it remains illegal under federal law. This dichotomy creates significant legal challenges for health care providers. Our attorneys leverage their experience in helping clients navigate health care regulations, such as HIPAA laws and patient privacy protections, and apply it to the uniquely complex environment surrounding the cannabis industry. We defend clients against civil claims, including medical malpractice matters, and can assist health care providers—including physicians, dispensaries and clinics—in understanding the evolving standards of care for cannabis as a therapeutic option, which can differ significantly from conventional treatments. Such claims may involve appropriate patient evaluations, dosage recommendations, and documentation requirements within the framework of state medical cannabis programs. We are also well-equipped to address challenges related to informed consent.  As the legal and regulatory frameworks surrounding cannabis continue to evolve, so too do the risks and complexities faced by businesses operating within this area. Our Cannabis Law Practice Group stands at the forefront of this rapidly developing field, providing clients with informed, strategic, and results-oriented counsel. Our multidisciplinary approach—spanning coverage, liability, cybersecurity, employment, workers’ compensation, and health care—ensures that clients receive comprehensive support tailored to the unique challenges of the cannabis industry. Whether addressing emerging claims or guiding proactive risk management, our team is committed to protecting our clients’ interests and positioning them for continued success in this dynamic legal landscape. Kristen works in our Philadelphia, PA office and can be reached at 215-575-2849 or KLWorley@mdwcg.com. Todd works in both our Philadelphia, PA and Mount Laurel, NJ offices. He can be reached at 215-575-2605, 856-414-6029 or TJLeon@mdwcg.com.  Defense Digest, Vol. 31, No. 4, December 2025, is prepared by Marshall Dennehey to provide information on recent legal developments of interest to our readers. This publication is not intended to provide legal advice for a specific situation or to create an attorney-client relationship. ATTORNEY ADVERTISING pursuant to New York RPC 7.1. © 2025 Marshall Dennehey. All Rights Reserved. This article may not be reprinted without the express written permission of our firm. For reprints, contact tamontemuro@mdwcg.com.

Defense Digest

Including Settled Defendants on a Verdict Sheet: A Reminder that No Assumptions Are Allowed

December 1, 2023

Key Points: Pennsylvania’s Fair Share Act permits the inclusion of a defendant or other non-party who has entered into a release with a plaintiff to be included on the verdict sheet and, thus, subject to apportionment of liability “… upon appropriate requests and proofs by any party.”  Employers who are granted immunity from liability and suit under Pennsylvania’s Workers’ Compensation Act are not subject to inclusion on a verdict sheet.  Trial of any case necessarily comes at the conclusion of months, and, in many instances, years, of discovery. Practitioners carefully weigh their strategy when propounding and answering written discovery, asserting objections during depositions, and serving expert reports. During this phase, it is easy to push the notion of trial and all of its practical considerations to the side, acknowledging the oft-cited statistic that only 1% of cases will reach the trial stage. Nevertheless, when those few cases we encounter in our practice reach the trial stage, we find ourselves preparing in earnest for testimony, crafting arguments for the admission or exclusion of evidence, as the case may be, and finally, preparing a litany of pretrial submissions. It is this latter subset of considerations, and specifically the verdict sheet, that are ultimately submitted to a jury which is the focus herein. A jury verdict sheet is the sum of every case expressed in its simplest form and, quite arguably, the most important document in any trial. The verdict sheet outlines for a jury the decisions that must be rendered once all the evidence has been placed before it. The form can take any number of versions, but in the traditional case, it directs a jury to determine liability, causation, and damages. But who goes on the verdict sheet? We expect that parties to a lawsuit will be placed on a verdict sheet, but what about settled defendants and non-parties? A defendant has a significant interest in providing a jury with the opportunity to apportion fault to as many entities as possible, thereby reducing its overall exposure.  Pennsylvania’s Fair Share Act, 42 Pa.C.S. § 7102, directs practitioners as to those instances in which settled defendants and non-parties may be included on a verdict sheet for purposes of apportionment of liability. 42 Pa.C.S. § 7102(a)(2) provides as follows: Apportionment of responsibility among certain nonparties and effect.--For purposes of apportioning liability only, the question of liability of any defendant or other person who has entered into a release with the plaintiff with respect to the action and who is not a party shall be transmitted to the trier of fact upon appropriate requests and proofs by any party. A person whose liability may be determined pursuant to this section does not include an employer to the extent that the employer is granted immunity from liability or suit pursuant to the act of June 2, 1915 (P.L.736, No.338), known as the Workers’ Compensation Act.  Note the key phrase in the foregoing citation, “…any defendant or other person who has entered into a release with the plaintiff with respect to the action and who is not a party shall be transmitted to the trier of fact upon appropriate requests and proofs by any party.” (Emphasis added.) Significantly, Pennsylvania courts have determined that there is no absolute right to the inclusion of a settled defendant on a verdict sheet. Hyrcza v. West Penn Allegheny Health System, Inc,. 978 A.2d 961, 969-970 (Pa. Super. 2009). Rather, a jury must be presented with proofs sufficient to find the settled defendant or other person liable, and the trial court functions as the gate keeper to determine whether that evidential burden has been satisfied. Ultimately, a trial court’s determination of whether sufficient evidence has been adduced that supports a prima facie case against a settled defendant and, thus, its inclusion on a verdict sheet is a decision that is subject to review for an abuse of discretion or error of law. See Rose v. Annabi, 934 A.2d 743, 745 (Pa. Super. 2007). An abuse of discretion occurs when the decision of the trial court represents “not merely an error of judgment, but where the judgment is manifestly unreasonable or where the law is not applied or where the record shows that the action is a result of partiality, prejudice, bias, or ill will.” Id. In discussing this standard of review, practitioners must take note that the decision of the trial court concerning the inclusion of a settled defendant or other person on a verdict sheet will be, for better or worse, a difficult ruling to challenge on appeal, and one should prepare their trial proofs accordingly.  In converse to settled defendants that may be placed on a verdict sheet following the submission of sufficient evidence of fault, employers who are granted immunity under the Pennsylvania’s Workers’ Compensation Act are not subject to inclusion on a verdict sheet. The exclusivity provision of the Pennsylvania Workers’ Compensation Act, set forth at 77 P.S. § 481, provides that the “liability of an employer under this Act shall be exclusive and in place of any and all other liability to such employees … entitled to damages in any action at law or otherwise on account of any injury or death … .” Acknowledging the Act’s limitation of suit, or exclusivity provision, the Pennsylvania Fair Share Act similarly bars the apportionment of any liability to an employer immunized from liability or suit under the Act. In sum, practitioners should not presume that defendants or non-parties who have entered into a release with the plaintiff will automatically be included on the verdict sheet. Rather, they should prepare their cases for trial with special attention paid to expert discovery and advance theories of liability against a settled entity. In this manner, practitioners can ensure that they are capable of presenting sufficient proofs from which the trial court can conclude that a prima facie case of liability has been advanced against a settled entity and, thereby, order the inclusion of said entity on the verdict sheet for purposes of liability apportionment.  *Kristen, a shareholder in our Philadelphia, Pennsylvania, office, is Co-Chair of our firm’s Catastrophic Claims Litigation Practice Group. She can be reached at 215.575.2849 or KLWorley@mdwcg.com.   Defense Digest, Vol. 29, No. 4, December 2023, is prepared by Marshall Dennehey to provide information on recent legal developments of interest to our readers. This publication is not intended to provide legal advice for a specific situation or to create an attorney-client relationship. ATTORNEY ADVERTISING pursuant to New York RPC 7.1. © 2023 Marshall Dennehey. All Rights Reserved. This article may not be reprinted without the express written permission of our firm. For reprints, contact tamontemuro@mdwcg.com.

Firm Highlights

Thought Leadership

Casual Care, Serious Consequences: How Informal Prescribing Can Trigger Medical Board Scrutiny

The lesson for health care practitioners is that regular review of the regulatory requirements can ensure compliance and that casual prescribing may be in violation of state regulations if the necessary components are not met. Consider the following scenario: in December 2025, a medical provider renewed a prescription for a long-standing telemedicine patient receiving a Schedule II controlled dangerous substance. This was not a violation of the New Jersey Administrative Code. Another provider doing the same action for an equally situated patient in March 2026 would be in violation. The casual prescriber who is not aware of newer regulatory requirements may have a more difficult time responding to a medical board complaint. Medicine is a highly-regulated helping profession. Without addressing the merits of this regulatory burden, the practice of medicine continues to see drastic changes impacting the everyday life of patient and provider. Telemedicine, COVID-19, and other advances and roadblocks, present a challenge to those saving lives while attempting to comply with the rules of practice. Physicians often discover—through real cases and the lens of regulatory expectations—that even well-intentioned informal help can be reinterpreted as stepping outside mandated professional boundaries, and seemingly harmless actions can be construed as deviations from required practice standards specifically outlined in Title 13, Chapter 35, Subchapters 7.1A of the New Jersey Administrative Code. Title 45, "Professions and Occupations," of the New Jersey code governs the practice of medicine, nursing, optometry, pharmacy, and many other professional occupations. Section 9 specifically addresses the state board of medical examiners and allows for the creation of rules and regulations in Section 45:9-5.3. These regulations can be found in the New Jersey Administrative Code Title 13, Chapter 35. While broad in scope, Chapter 35 contains a subchapter dedicated to the administration and dispensing of prescription drugs. Such knowledge will arm physicians with the tools they need to prevent a negative outcome if a medical board complaint is filed. Likewise, attorneys must be familiar with these regulatory requirements when advising and defending providers. In New Jersey, N.J.A.C. Section 13:35-7.1A(a) requires that a practitioner conduct an examination and appropriately document the same within the medical record before dispensing drugs or issuing prescriptions. The examination must include an "appropriate history and physical examination," a diagnosis based upon the examination and any testing consistent with good medical care, the formulation of a therapeutic plan discussed with the patient, and the availability of appropriate follow-up care. There are only six exceptions to this requirement: In admission orders for a newly hospitalized patient For a patient of another physician for whom the practitioner is taking calls For continuation medications on a short-term basis for a new patient prior to the patient's first appointment For an established patient who, based on sound medical practice, the physician believes does not require a new examination before issuing a new prescription For a patient examined by a healthcare professional who is in collaborative practice with the practitioner When treatment is provided by a practitioner for an emergency medical condition Emergencies are also limited to situations where someone's health is in serious jeopardy, there is serious impairment to bodily functions, or serious dysfunction of any bodily organ or part. During the COVID-19 pandemic, then New Jersey Governor Phil Murphy issued an executive order declaring a public health emergency and a state of emergency that allowed authorized prescribers to prescribe Schedule II controlled dangerous substances via telemedicine. The order was terminated when he left office earlier this year and the state reverted to the requirement of an initial in-person examination and quarterly in-person visits. With this return to prior regulatory requirements, practitioners subject to the jurisdiction of the board of medical examiners may benefit from a refresher on the regulatory limitations on their practice now that the pandemic-era flexibilities have ended. This new requirement may create confusion for prescribers and lead to casual prescribing of medication in violation of the regulations, even in the setting of recurrent telemedicine appointments as noted in the example above. Casual prescribing can take many forms: filling a prescription request from a friend or family member without an examination or contemporary medical record; using telemedicine to expand your practice without proper in-person appointments or documentation in the medical record; failing to ensure appropriate follow-up care for a "one time" prescription; etc. Although not all board complaints end in a publicly available opinion, serious deviations from regulatory requirements can shine a light on practices that will require action by the board if a complaint is received. Consider the following cases: In October 2025, the board issued a final consent order in an administrative action where a doctor provided opioids without examination and his license was permanently revoked. In re Robert Dela Gente, D.O., N.J. State Bd. of Med. Exam'rs Oct. 21, 2025. Criminal charges were filed (though that is not always the case). In a September 2025 consent order, a physician was reprimanded for "prescribing opioids several months in advance without the proper patient follow-up..." and explained that they did so for "patients who can not pay for multiple visits to refill medications." In re A/an E. Schultz, M.D., N.J. State Bd. of Med. Exam'rs Sept. 25, 2025. Another physician was suspended and placed on probation in a consent order for prescribing three patients the weight-loss medication "Ozempic" via text messages through a website called "Push Health" and without any further communication with the patients or taking a medical history. In re Laura E. Purdy, M.D., N.J. State Bd. of Med. Exam'rs Aug. 29, 2025. A June 2025 interim consent order required a "full evaluation and assessment of [a physician's] general knowledge and skill, with specific emphasis on his knowledge of and ability to safely prescribe [controlled dangerous substances]" due to his failure to review a patient's prior medical history and medical record, assess and review the prescription monitoring program before prescribing CDS, and conduct random urine screens on a patient that tested positive for CDS upon admission to his practice because "he trusted the patient." In re Donald Oh, M.D., N.J. State Bd. of Med. Exam'rs June 2, 2025. Each of these examples demonstrate a failure to follow strict procedure regardless of the intention. Failing to follow procedure secondary to good intentions, such as considering a patient's financial constraints, trust in the patient, or utilizing a new telemedicine service platform, will not be a defense to a board complaint. Especially when practicing via telemedicine, practitioners must ensure they are adhering to the appropriate regulatory standard. A provider who calls in a prescription for a traveling friend or family member or agrees to prescribe medication for individuals using the newest phone app will have a hard time meeting the requirements of N.J.A.C. Section 13:35-7.1A. Even if a history was taken, a "therapeutic plan" was created, and "follow up care" was provided, the prescriber would still not be in compliance with the regulation without an in-person examination. In our opening hypothetical, the prescriber's behavior did not change between December and March; however, the legal shift in the regulatory landscape made once acceptable behavior a violation as a required examination did not occur. When complaints are made with regard to informal prescribing, the board has discretion to employ measures to encourage compliance in lieu of formal proceedings such as a private, written warning; suspending fines subject to continuing compliance; medical or professional treatment as may be necessary; medical or diagnostic testing and monitoring; skills assessment; corrective training; participation in outreach programming; or contribution to the consumer fraud protection fund. The lesson for health care practitioners is that regular review of the regulatory requirements can ensure compliance and that casual prescribing may be in violation of state regulations if the necessary components are not met. Even compliant providers who had not conducted an in-person examination for telemedicine patients during the COVID-19 emergency would be in violation of the regulations as of January 2026 for the same practice. Practitioners should be diligent in adhering to the prescribing rules to avoid sanctions related to casual care. Likewise, attorneys advising or defending practitioners before the board must be aware of the in-person examination requirements for prescribing in New Jersey whether the care in question took place in-person or in a telemedicine setting. Reprinted with permission from the April 22, 2026 issue of the New Jersey Law Journal. ©2026 ALM Media Properties, LLC. Further duplication without permission is prohibited. All rights reserved.

Result

No-Cause Jury Verdict Secured in Wrongful Death Trial

We successfully obtained a no-cause jury verdict in a 13-day wrongful death trial. The decedent, a 59-year-old man, was admitted to the emergency room on February 15, 2019, with complaints of abdominal pain, decreased appetite, and constipation, despite the use of laxatives. The patient did not complain of any nausea, vomiting, or diarrhea. He had a significant medical history including diabetes, hypertension, prior coronary artery stenting, morbid obesity (with past gastric bypass surgery), longstanding ventral hernia, and back pain. A CT scan revealed multiple hernias and a potential closed-loop bowel obstruction, leading to a surgery consultation. Our client, an emergency general surgeon, interpreted that the patient did not have a closed loop or any significant obstruction and recommended non-surgical management. The patient was approved to have clear liquids, and had a vomiting incident shortly after, but our client was not notified. The patient was returned to NPO status, and after improving overnight, he was returned to “clears” and additional medical and renal consults were ordered. Our client did not receive any communications from the residents/nurses of any changes in the patient’s condition. On February 18, 2019, two rapid responses were called due to increased heart rate and vomiting. It is believed that the vomiting resulted in aspiration, causing sepsis, ultimately leading to the patient’s death. During the trial, the plaintiff’s sole medical expert highlighted imaging on the wrong hernia, which called into question all of his opinions in the case. We made key objections related to the expert testimony, limiting what the allegations were, and preventing new allegations from being made. After approximately two and a half hours of deliberating, the jury returned a no-cause verdict. 

News

Marshall Dennehey’s John J. Hare Brings Home Attorney of the Year Honors; Firm Named Litigation Department of the Year in Two Categories

Marshall Dennehey took home top honors in three categories at the The Legal Intelligencer’s 2026 Pennsylvania Legal Awards, held June 11 in Philadelphia. The first place awards include: Attorney of the Year: John J. Hare, Chair of the firm’s Appellate Advocacy & Post-Trial Practice Group and Executive Committee member, together with Charles “Chip” Becker of Kline & Specter Litigation Department of the Year, Appellate – Third Win in a Row! Litigation Department of the Year, Product Liability/Mass Torts “There is no one more deserving of Attorney of the Year honors than John. This award is a testament to his exceptional skill, dedication, and leadership—qualities that truly exemplify the very best of our firm,” said G. Mark Thompson, Marshall Dennehey’s President & CEO. “These honors also reflect the strength and depth of our product liability, mass torts, and appellate practices across Pennsylvania and beyond, underscoring our ongoing commitment to delivering outstanding results for our clients.” Attorney of the Year – John J. Hare, Marshall Dennehey, together with Charles “Chip” Becker, Kline & Specter Over the past year, John and Charles were opposing counsel in many of the highest-profile civil appeals in Pennsylvania. John is renowned as a preeminent appellate lawyer on the defense side, and Chip on the plaintiff's side. They have opposed each other repeatedly, exhibiting peerless professionalism and exceptional civility, while zealously litigating under the unremitting pressure of high-profile litigation and record-setting verdicts totaling more than $3.5 billion. They have also collaborated, outside of litigation, on many commissions, committees, and projects of importance to the Pennsylvania judiciary and legal community. Litigation Department of the Year – Appellate Law, Winner (previous winner, 2025 and 2024) 2025 was another standout year for the firm’s Appellate Advocacy & Post‑Trial Practice Group, led by John J. Hare, which was retained to challenge many of Pennsylvania’s “nuclear” verdicts—awards exceeding $10 million. Notably, the department persuaded the Pennsylvania Superior Court to reverse a Philadelphia judgment of $1.09 billion, the largest judgment ever overturned by a Pennsylvania appellate court. The group’s 11 full‑time Pennsylvania‑based appellate lawyers are at the center of Pennsylvania’s most high-profile matters, bringing more than 150 years of combined appellate experience. They routinely handle post‑trial and appellate matters and are frequently engaged to participate in and monitor trials in high‑exposure cases to ensure that critical legal issues are properly raised and preserved for appeal. Litigation Department of the Year – Product Liability/Mass Torts, Winner This marks the first win for the firm’s Pennsylvania Product Liability and Mass Torts practices, which operate within our Casualty Department, managed by Matthew Schorr and Jeff Rapattoni. For almost five decades, Fortune 500 product manufacturers/distributors and their insurers have turned to these groups to defend their litigation. Led by Bradley D. Remick and Vlada Tasich, our Product Liability group’s success can be attributed to its commitment to keeping abreast of ever-changing legal theories, judicial viewpoints, and evolving technology impacting the product liability landscape. Our attorneys have successfully handled thousands of product liability matters in all jurisdictions across the state. Likewise, our mass tort litigation practice – divided into Asbestos & Mass Tort, and Environmental & Toxic Tort Litigation –  has defended manufacturers, distributors, contractors, and premises owners in thousands of personal injury and other claims. Led by Kevin E. Hexstall and Patrick T. Reilly, most attorneys in these groups have more than 20 years of experience, and our seasoned trial team has tried hundreds of cases to verdict, consistently achieving strong results through both trials and settlements. In addition to these awards, Marshall Dennehey was a Litigation Department of the Year finalist for Professional Liability.

Thought Leadership

SIDEBAR: News and Happenings

We are pleased to share that attorneys from our health care team have been selected to the 2026  New Jersey and Pennsylvania Super Lawyers and Rising Stars lists. Their dedication to clients and commitment to high-quality work continues to strengthen our firm! Please join us in congratulating: NJ Super Lawyers: Robert T. Evers and Justin F. Johnson NJ Super Lawyer Rising Stars: Nataliana A. Guida  2026 Pennsylvania Super Lawyers: Alyson J. Kirleis and Gary M. Samms 2026 Pennsylvania Rising Stars: Holli K. Archer and Daniel Dolente Victoria Scanlon (Scranton) was a faculty presenter at the 2026 American Roentgen Ray Society (ARRS) Annual Meeting in Pittsburgh. She participated in the “Resident Symposium: Producing Quality Reports,” focusing her presentation on “How to Write a Great Report: Malpractice Lawyer’s Perspective.” Vicky, the only attorney presenter for this two-hour segment, was joined by several health care professionals including diagnostic radiologists, an interventional radiologist, an internal medicine physician, and a radiologist turned AI entrepreneur expert.  Matthew Keris (Scranton), President of the Pennsylvania Association for Health Care Risk Management (PAHCRM) and shareholder in our Scranton Health Care Department, presented an important and timely session titled “Keynote Address: A Conversation with RaDonda Vaught on Criminalizing Errors” at PAHCRM’s Annual Meeting in April. RaDonda is a former Tennessee nurse widely known for being criminally convicted in 2022 of negligent homicide and gross neglect after a 2017 fatal medication error at Vanderbilt University Medical Center. Her case gained national attention because she was criminally prosecuted rather than just facing licensing board action, sparking debate over blaming individual nurses for systemic healthcare failures. Matt and RaDonda’s conversation explored one of the most consequential issues in health care risk management today—how systems respond to human error, and what it means for patient safety, accountability, and the professionals who serve on the front lines. Gary Samms was a panelist for a podcast hosted by the Medical Liability Monitor, “From Outliers to Pattern: The Increasing Predictability of Megaverdicts in the Med-Mal Industry – and How to Reduce the Likelihood of Getting Hit with One.” Gary discussed the changing megaverdict landscape and why “outlier” verdicts are becoming structural, in addition to how plaintiffs turn weaknesses into megaverdicts (including building emotional narrative and jury psychology). Thank you to our clients who joined us for our Trends in Health Care & Health Law seminar on May 14. Led by our Health Care Department Director and Assistant Director, Robin Snyder and Donna Modestine, the session explored key issues that are currently shaping outcomes in health care litigation. We owe a debt of gratitude to our esteemed guest speaker, Mary Ellen Nepps, Esq., Senior Counsel, University of Pennsylvania, who presented “Medical Malpractice Litigation: Driving Another Health Care Crisis in Pennsylvania.” And special thanks to our attorneys who presented and shared their insights, including John J. Hare and Holli Archer who discussed “Highlights in PA Medical Malpractice Law;” David Drake for his presentation, “From Claims to Courtroom: Key Trends in NJ Medical Malpractice Litigation;” and Matthew Keris with an “Update on Health Care Tech Discovery.” Thank you to all of our clients for entrusting us with your health care litigation. We are proud to partner with you as we defend your interests and navigate legal landscapes together.